Pharming Group Begins Leniolisib Phase II Trial
PremiumCompany AnnouncementsPharming Group Begins Leniolisib Phase II Trial
1M ago
Pharming Group’s New APDS Drug Wins U.K. Approval
Premium
Company Announcements
Pharming Group’s New APDS Drug Wins U.K. Approval
2M ago
Pharming Group Sees Strong Revenue Growth in Q2
Premium
Company Announcements
Pharming Group Sees Strong Revenue Growth in Q2
3M ago
Pharming Group price target lowered to EUR 1.75 from EUR 2.10 at RBC Capital
PremiumThe FlyPharming Group price target lowered to EUR 1.75 from EUR 2.10 at RBC Capital
9M ago
Pharming management to meet with Oppenheimer
Premium
The Fly
Pharming management to meet with Oppenheimer
11M ago
Pharming management to meet with Oppenheimer
Premium
The Fly
Pharming management to meet with Oppenheimer
11M ago
Pharming management to meet with Oppenheimer
PremiumThe FlyPharming management to meet with Oppenheimer
2y ago
Pharming management to meet with Oppenheimer
Premium
The Fly
Pharming management to meet with Oppenheimer
2y ago
Pharming Novartis announces first commercial shipments of Joenja in U.S.
Premium
The Fly
Pharming Novartis announces first commercial shipments of Joenja in U.S.
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100